HCV prevention, testing and treatment for people who inject drugs: A global and country perspective

ISSUP are pleased to present this webinar on hepatitis C care for people who inject drugs. The webinar will focus in on prevention, treatment and the barriers and facilitators to accessing support and will highlight guidelines that have been produced to develop treatment programmes. It will furthermore highlight lessons learned from an innovative project from Thailand lead by the Dreamlopments Foundation.

Speakers:

Dr Niklas Luhmann is a medical doctor with a Master of Science (Msc) in International Public Health from the University of Berlin. He has been working for more than 10 years with different institutions on access to healthcare with a focus around HIV and viral hepatitis related prevention, treatment and care. He joined WHO headquarters in Geneva in 2019 where he works as a technical officer and leads the work on viral hepatitis prevention, testing and priority populations.

Dr. Tanyaporn Wansom is an infectious diseases specialist and public health expert based in Bangkok, Thailand. She holds an MD and Master’s in public policy from the University of Michigan and PhD in clinical research from Johns Hopkins School of Public Health. Her areas of expertise include HIV, viral hepatitis, and sexually transmitted infections.  She currently serves as Director of Research at Dreamlopments Foundation and is protocol chair of the C-Free Study. In addition, she volunteers as a study physician at the Thai Red Cross AIDS Research Centre and is an investigator on the Hepatitis Transformative Science Committee of the AIDS Clinical Trial Group (ACTG).

Webinars and online events delivered and hosted by the International Society of Substance Use Professionals (ISSUP) are provided for informational purposes only. They are educational in nature and do not constitute medical advice, diagnosis or treatment.